This video has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines Live.
View FERACCRU® (ferric maltol) adverse event reporting and prescribing information
UK-HAE-FER-2200003 | March 2022
Please sign in using your login details for accessing guidelinesinpractice.co.uk.
If you do not have an account please register (for free) via the button below.